Better Therapeutics, Inc.
BTTXDelisted- Industry
- Services-Health Services
- SEC CIK
- 0001832415
Better Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Feb 13, 2024; 1 institution reported holding it in 13F filings for Q4 2025, worth $0 in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 1
- Q4 2025, 0 vs. previous quarter
- 13F value
- $0
- Reported value at the end of Q4 2025
- Superinvestors holding
- 0
- At the end of Q4 2025
Superinvestors holding BTTX, Q4 2025
No superinvestor reported holding BTTX at the end of Q4 2025.
Latest insider trades
Open-market purchases and sales by Better Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Perry David PExecutive Chairman | PPurchase | +1.23M | $0.73 | +$900.1K | +10.5%13.0M after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Berman Mark A.Chief Medical Officer | PPurchase | +54.8K | $0.73 | +$40.0K | +16.4%388.2K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Armanino Andrew J.Director | PPurchase | +274.0K | $0.73 | +$200.0K | +60.3%728.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Granger ElderDirector | PPurchase | +34.3K | $0.73 | +$25.0K | +2,140.7%35.9K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Karbe FrankChief Executive Officer | PPurchase | +137.0K | $0.73 | +$100.0K | +46.9%429.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Parker Geoffrey M.Director | PPurchase | +685.0K | $0.73 | +$500.1K | +199.7%1.03M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Granger ElderDirector | PPurchase | +600 | $0.87 | +$522 | +60.0%1.60K after | |
| Apr 12, 2023 (view filing)9:44 PM ET | Apr 10 | 2 days | Perry David P and 1 otherSee Remarks | PPurchase | +4.97M | $0.825 | +$4.10M | New position3.64M after | 2 lots |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Karbe FrankSee Remarks | PPurchase | +242.4K | $0.83 | +$201.2K | +484.8%292.4K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Parker Geoffrey M.Director | PPurchase | +303.0K | $0.83 | +$251.5K | +757.6%343.0K after |
Top 10 13F holders, Q4 2025
The largest institutional positions in Better Therapeutics, Inc. at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 3,000 | $0 | 0.00% | 00.0% | Unchanged |